Smart drug choice: matching pills to your heart type may beat standard BP care
NCT ID NCT07240909
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 2 times
Summary
This study tests whether choosing blood pressure medication based on a person's specific heart and blood vessel measurements (hemodynamic phenotyping) works better than the usual guideline-based approach. About 240 adults with mild-to-moderate hypertension who have never taken blood pressure drugs will receive either a personalized drug (amlodipine, metoprolol, or indapamide) or standard treatment for 8 weeks. The goal is to see if the personalized method leads to greater blood pressure reduction with similar safety.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- amlodipine, metoprolol, or indapamide
- What this could lead to
- If it works, this could show that matching blood pressure drugs to a person's specific heart and blood vessel type leads to better blood pressure control than the usual one-size-fits-all approach.
- What could go wrong
- This is a relatively small, early-phase trial (240 people) that hasn't started yet. The personalized approach may not prove better than standard care, and results may not apply to everyone with hypertension.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HYPERTENSION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a few short nights of sleep tip the scales toward high blood pressure?
- Chatbot could put blood pressure control in Patients' hands
- Can a 5-Step chat help tame high blood pressure?
- Can artery scans reveal hidden damage from high blood pressure?
- CRISPR injection could rewrite the future of blood pressure control
- Text messages and nurses: a new strategy to tackle hypertension in tanzania?